Daniel Auclair

Peninsula Regional Medical Center — United States

Medicine · Health Sciences

54h-index35.4kcitations526works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(240), Protein Degradation and Inhibitors(80), Cancer Genomics and Diagnostics(62), Sarcoma Diagnosis and Treatment(42), Forest ecology and management(38)

Publications524 total

Supplementary Figures and Tables from MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
2025Open Access
Validation of a Rule-Based Algorithm for Line-of-Therapy Assignment in Multiple Myeloma Using Simulated Data
Clinical Lymphoma Myeloma & Leukemia·2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Nature Genetics·2025Open Access
Abstract 5559: Receptor tyrosine kinase-like orphan receptor 1 (ROR1) in BTKi-treated mantle cell lymphoma
Cancer Research·2025
DNA Methylation Analysis of Commpass Reveals Distinct Epigenetic Programs of High-Risk Disease
Blood·2024Open Access
Development of a High-Throughput Multiplex Immunofluorescence Pipeline in Classic Hodgkin Lymphoma Whole Slide Formalin-Fixed Paraffin-Embedded Tissue Samples
Blood·2024Open Access
Ectopic NSD2 Remodels H3K36me2 and DNA Methylation to Promote Oncogenic Gene Expression in Multiple Myeloma
Blood·2024
Dual role of signaling pathways in myeloma requires cell type–specific targeting of ligand-receptor interactions
Blood Advances·2024· 2 citedOpen Access
Abstract 3904: Multiplexed flow cytometry based immunophenotyping paired with functional <i>ex vivo</i> (MFLEX) drug profiling informs potential efficacy of therapeutic agents in acute myeloid leukemia
Cancer Research·2024
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
UNC Libraries·2024Open Access
Supplementary Methods 1 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
FIGURE 4 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Supplementary Figure 4 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Supplementary Table 5 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Supplementary Table 1 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Supplementary Methods 1 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Data from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Supplementary Figure 6 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Supplementary Table 4 from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
Data from Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
2023Open Access
page 1 of 27Next →

Frequent Co-authors

Gad Getz(20), Michael S. Lawrence(17), Kristian Cibulskis(17), Matthew Meyerson(15), Andrey Sivachenko(14), Scott L. Carter(13), Carrie Sougnez(13), Todd R. Golub(13), Alex H. Ramos(12), Stacey Gabriel(12), Jonathan J. Keats(12), Kenneth C. Anderson(12), Petar Stojanov(10), Gordon Saksena(10), Aaron McKenna(9), Trevor J. Pugh(9), Douglas Voet(9), Robert C. Onofrio(9), Levi A. Garraway(9), Eric S. Lander(9)